"Pulmonary & Sleep of Tampa Bay is one of the few specialty medical groups accredited by the Joint Commission, which means our office complies with the highest national standards for safety and quality of care and is committed to continually improving patient care. Our patients know they can trust us to listen to their concerns and provide safe, state-of-the-art, personalized diagnoses and treatment of pulmonary disease, lung cancer,allergies and sleep disorders. We have three convenient locations in the Tampa area, including in Brandon, Wesley Chapel, and Tampa."

During the past decade, Pulmonary and Sleep of Tampa Bay conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pulmonary and Sleep of Tampa Bay" #1 collaborator was "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pulmonary and Sleep of Tampa Bay" are "Lung Diseases, Interstitial" (2 trials), "Hospitalized Elderly" (1 trials), "Lung Lesion(s) Requiring Evaluation" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Pulmonary and Sleep of Tampa Bay" in a lesser frequency.

Most popular intervention types in "Pulmonary and Sleep of Tampa Bay" are "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (2 trials), "Electromagnetic Navigation Bronchoscopy" (1 trials), "ICS (Inhaled Corticosteroid) (Triple therapy)" (1 trials), "LABA (Long-Acting Beta Agonist) (Triple therapy)" (1 trials) and "LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pulmonary and Sleep of Tampa Bay" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Pulmonary and Sleep of Tampa Bay". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Pulmonary and Sleep of Tampa Bay, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pulmonary and Sleep of Tampa Bay, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".